Log in to your Inderes Free account to see all free content on this page.
BioGaia
116.80 SEK
+1.13 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia
P/E
Median 2019-2025
EV/S
Median 2019-2025
EV/EBIT
Median 2019-2025
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 84.90 | 107.40 | 103.60 | 83.57 | 101.20 | 111.90 | 106.20 |
| Shares | 86.7 | 89.3 | 101.0 | 101.0 | 101.0 | 101.2 | 101.2 |
| Market cap | 7,359.1 | 9,588.1 | 10,461.5 | 8,439.1 | 10,219.4 | 11,320.0 | 10,743.4 |
| Enterprise value | 7,145.3 | 8,120.3 | 8,976.8 | 6,950.7 | 8,675.2 | 10,096.0 | 9,942.1 |
| EV/S | 9.3 | 10.9 | 11.4 | 6.3 | 6.7 | 7.1 | 6.5 |
| EV/EBITDA | 27.7 | 32.7 | 31.9 | 18.0 | 18.5 | 20.2 | 22.7 |
| EV/EBIT | 29.5 | 35.6 | 35.4 | 19.2 | 19.6 | 23.8 | 24.1 |
| P/E | 39.3 | 53.3 | 53.3 | 22.6 | 28.0 | 32.2 | 32.3 |
| P/B | 14.49 | 5.49 | 5.57 | 4.28 | 5.03 | 6.57 | 8.17 |
| P/S | 9.6 | 12.8 | 13.3 | 7.6 | 7.9 | 8.0 | 7.0 |
| Dividend yield | 0.9 % | 0.6 % | 0.7 % | 3.5 % | 6.8 % | 6.2 % | 3.8 % |
| Equity ratio | 76.3 % | 91.3 % | 88.2 % | 89.1 % | 87.0 % | 84.8 % | 82.3 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users